Detalhe da pesquisa
1.
Tumor Selective Silencing Using an RNAi-Conjugated Polymeric Nanopharmaceutical.
Mol Pharm
; 13(3): 737-47, 2016 Mar 07.
Artigo
Inglês
| MEDLINE | ID: mdl-26835715
2.
Discovery of a Novel Cabazitaxel Nanoparticle-Drug Conjugate (CRLX522) with Improved Pharmacokinetic Properties and Anticancer Effects Using a ß-Cyclodextrin-PEG Copolymer Based Delivery Platform.
J Med Chem
; 62(21): 9541-9559, 2019 11 14.
Artigo
Inglês
| MEDLINE | ID: mdl-31593466